Tuesday, August 19, 2014 2:39:17 PM
Keep in mind, disclosure requirements state that the number of shares outstanding listed must include any and all issuances or other activities that are disclosed in the report. As all of the items you listed are in the report, then they must be tallied into the reported number of total shares outstanding.
This does not mean that the company won't issue more shares in the future, but as far as where things stand now, it appears that they have reduced the outstanding by over 12%, INCLUDING the shares issued to the new investor and for the transaction.
Simply put, over 19 million shares appear to have been retired and 10m were issued, meaning a total reduction of over 9 million shares outstanding.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM